Última Hora: "Offshore: IGF diz que Fisco realizou um terço das acções de controlo planeadas entre 2009 e 2013 - Jornal de Negócios - Portugal" Tue, 27 Jun 2017 23:16:00 GMT    "Bruxelas aplica à Google uma multa recorde de 2,4 mil milhões de euros por abuso de posição dominante - Diário de Notícias - Lisboa" Tue, 27 Jun 2017 11:10:04 GMT    "Uber anuncia alargamento da atividade a toda a costa algarvia - Jornal de Notícias" Tue, 27 Jun 2017 23:59:00 GMT   "Ataque informático mundial atinge farmacêutica Merck e central nuclear Chernobyl - Expresso" Tue, 27 Jun 2017 18:38:00 GMT    "Governo pondera baixar IRS a senhorios que ofereçam contratos de arrendamento de longa duração - Expresso" Wed, 28 Jun 2017 08:46:06 GMT    "Reforma aos 60 anos sem cortes custaria 730 milhões em 2019 - Diário de Notícias - Lisboa" Tue, 27 Jun 2017 23:02:00 GMT    "Depois dos copos e das mulheres, as "Dijsselbloem Nights" - TVI24" Tue, 27 Jun 2017 14:45:00 GMT    "Draghi: Os salários na Europa já são mais flexíveis, mas apenas para baixo - Público.pt" Wed, 28 Jun 2017 06:13:01 GMT    "Internet e email no SNS desligados após ciberataque global - TSF Online" Tue, 27 Jun 2017 18:45:00 GMT    "CP propõe viagem no tempo pela linha do Douro em comboio dos anos 1940 - Observador" Tue, 27 Jun 2017 14:27:00 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Activo não encontrado Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última TradeRange 52 Semanas[0,000 - 0,000]
Hora da Última TradeN/A - N/APrice-Target 1 AnoN/A
Variação ()Capitalização Bolsista3
Bid / AskN/AEPS0,00
AberturaPER12,69%
MáximoPagamento DividendoN/A
MínimoData Ex-DividendoN/A
Fecho Anterior0,000YieldN/A
VolumeVolume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de Sepracor Inc. -  [Ticker: SEPR]
Mudar para Gráfico de Análise Técnica Interactiva de Sepracor Inc.

Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:
Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)

Board Change
London South East (registration) (blog)
He has also held senior management positions at Sepracor, Inc. (now Sunovion Pharmaceuticals, Inc.), Accenture plc and GlaxoWellcome plc (now GlaxoSmithKline plc). ?Trevor trained as a microbiologist at University of Reading, obtaining a PhD in ...


Flex Pharma (FLKS) Says Christoph Westphal to Transition From Role as CEO, Remain as Chair; William McVicar ...
StreetInsider.com
Flex Pharma, Inc. (NASDAQ: FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments for cramps and spasticity associated with severe neurological diseases including amyotrophic lateral sclerosis (ALS ...

e mais »

Desloratadine Market Analysis and In-Depth Analysis on Market Dynamics, Emerging Trends, Growth Factors and ...
satPRnews (press release)
Desloratadine Market Key Players Analysis: Pfizer, Teva, Wante Pharmaceutical?, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin ...

e mais »

Frequency Therapeutics Announces its Board of Directors and the Appointment of Marc A. Cohen as Chairman
Yahoo Finance
The Board Members include Tim Barberich, founder and former CEO and Chairman of Sepracor, Inc. (now known as Sunovion), Marc Kozin, Senior Advisor and former President of L.E.K. Consulting, Robert S. Langer, Sc.D., Frequency Co-founder and the ...

e mais »

Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
Business Wire (press release)
?With their successful partnership from their time at Sepracor, Bill and our CMO, Dr. Tom Wessel, are a great team to rapidly advance our Phase 2 clinical trials in MS, ALS and Charcot-Marie-Tooth with FLX-787 which will be amongst the most advanced ...

e mais »

Genzyme Corporation Pays $5.885 Million To Resolve False Claims Act Allegations; Judgment Involving Cases ...
PR Newswire (press release)
Those defendants include Allergan, Inc., Amgen, Inc., Bradley Pharmaceuticals, Inc., Eisai, Inc., Mallincrodt, Inc., Novo Nordisk, Inc., Reliant Pharmaceuticals, Inc., Sepracor, Inc., and Upsher-Smith Laboratories, Inc. The settlement with Genzyme ...

e mais »

Hants Journal

Charlottetown's BioVectra expanding, setting up in Windsor
Hants Journal
In June, BioVectra, which produces ingredients for the global pharmaceutical industry, purchased the former Sepracor Canada Limited building in Windsor's industrial area. The company will upgrade the 55,000 square foot manufacturing facility for their ...

e mais »

Rewire

Religious Imposition Proponents Find an Ally in the White House
Rewire
Stirrup worked as a senior legislative adviser at Venable LLP from 2003 to 2008. The firm's clients between those years included AstraZeneca Pharmaceuticals, Sepracor Inc, and the National Association of Spine Specialists. Another hire, Anna Pilato, is ...


Sunovion Pharmaceuticals Inc. Announces Company Name Change
Business Wire (press release)
BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion), formerly Sepracor Inc. (Sepracor), announced today that it has formally changed its name. The change occurs on approximately the one year anniversary of the acquisition of Sepracor by ...

e mais »

Sunovion Celebrates Five-Year Anniversary Milestone
Business Wire (press release)
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) announced today that it is celebrating its five-year anniversary. Sunovion was established in October 2010 following the integration of Sepracor Inc. and Dainippon ...

e mais »

Boston Globe

Sunovion gets OK for its epilepsy drug
Boston Globe
Marlborough biotech Sunovion Pharmaceuticals Inc. is preparing to start selling a new antiseizure pill early next year, following Food and Drug Administration approval of the medication. FDA regulators signed off on Sunovion's first epilepsy drug ...

e mais »

Psychiatric Implications of Neurological Disorders: May 2017
Healio
Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly ...


Cabot Corporation Names New Vice President of Investor Relations
Business Wire (press release)
Prior to joining Cabot, Mr. Delahunt held several senior financial positions including Vice President and Treasurer for Sepracor Inc. and Vice President and Treasurer for PerkinElmer, Inc. Delahunt earned his MBA and BS in Business Administration from ...

e mais »

PMLiVE

Astellas appoints ethics and compliance and US legal leaders
PMLiVE
Wanda brings over 20 years of experience in the pharmaceutical industry, having held senior leadership positions at Schering-Plough and Sepracor Inc, a US-based biopharmaceutical company. Prior to joining Astellas as deputy general counsel and head of ...


Reuters

Dainippon to buy US drug firm Sepracor for $2.6 billion
Reuters
BOSTON/TOKYO Dainippon Sumitomo Pharma Co Ltd agreed on Thursday to buy U.S. drugmaker Sepracor Inc for $2.6 billion, giving the Japanese firm a big, local sales force in the world's largest drugs market. The deal is the latest in a string of overseas ...

Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc.

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2017 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters